{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:32:11Z","timestamp":1782311531680,"version":"3.54.5"},"reference-count":47,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OVS"],"published-print":{"date-parts":[[2006,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>Choroidal neovascularization (CNV) is a common cause of vision loss in patients &lt;50 years of age. In these patients, CNV is often the result of pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, or idiopathic causes. Rarely, CNV is seen in children, usually in association with inherited macular dystrophies such as Best's disease (vitelliform macular dystrophy) or drusen of the optic nerve. This article discusses the role of optometrists in the detection and management of CNV. Untreated CNV can cause rapid deterioration of central vision and is associated with a poor prognosis. Optometrists may be able to improve the prognosis of younger patients with CNV by recognizing the signs, symptoms, and risk factors for CNV and promptly referring patients with suspected CNV to a retina specialist. They can also help patients by providing long\u2010term support and rehabilitation. Recent treatment advances, such as the availability of verteporfin (Visudyne; Novartis Pharma AG, Basel, Switzerland) therapy, that are applicable to younger patients with CNV have increased the importance of early detection of CNV and prompt referral of patients to a specialist who can treat CNV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/01.opx.0000216019.88256.eb","type":"journal-article","created":{"date-parts":[[2006,5,10]],"date-time":"2006-05-10T04:37:16Z","timestamp":1147235836000},"page":"316-325","source":"Crossref","is-referenced-by-count":41,"title":["Vision Loss in Younger Patients: A Review of Choroidal Neovascularization"],"prefix":"10.1002","volume":"83","author":[{"given":"David G.","family":"Miller","sequence":"first","affiliation":[{"name":"Retina Associates of Cleveland, Inc. Cleveland Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Singerman","sequence":"additional","affiliation":[{"name":"Retina Associates of Cleveland, Inc. Cleveland Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,5,1]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00055735-199906000-00005","article-title":"Choroidal neovascularization in younger patients","volume":"10","author":"Spaide RF","year":"1999","journal-title":"Curr Opin Ophthalmol"},{"key":"e_1_2_9_3_1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0161-6420(96)30515-0","article-title":"Etiology of choroidal neovascularization in young patients","volume":"103","author":"Cohen SY","year":"1996","journal-title":"Ophthalmology"},{"key":"e_1_2_9_4_1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00055735-200106000-00014","article-title":"Natural history of choroidal neovascularization in high myopia","volume":"12","author":"Miller DG","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"e_1_2_9_5_1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0161-6420(01)00544-9","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1\u2010year results of a randomized clinical trial\u2014VIP report no. 1","volume":"108","author":"Verteporfin In Photodynamic Therapy (VIP) Study Group","year":"2001","journal-title":"Ophthalmology"},{"key":"e_1_2_9_6_1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/112067219700700401","article-title":"Long\u2010term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment","volume":"7","author":"Secretan M","year":"1997","journal-title":"Eur J Ophthalmol"},{"key":"e_1_2_9_7_1","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/S0161-6420(84)34113-6","article-title":"Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis","volume":"91","author":"Olk RJ","year":"1984","journal-title":"Ophthalmology"},{"key":"e_1_2_9_8_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archopht.1993.01090010021006","article-title":"Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: results of a pilot randomized clinical trial","volume":"111","author":"Fine SL","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_9_9_1","first-page":"309","article-title":"Understanding angioid streaks","volume":"68","author":"Gurwood AS","year":"1997","journal-title":"J Am Optom Assoc"},{"key":"e_1_2_9_10_1","first-page":"747","article-title":"Choroidal neovascularization: a wound healing perspective","volume":"9","author":"Kent D","year":"2003","journal-title":"Mol Vis"},{"key":"e_1_2_9_11_1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0002-9394(14)76618-8","article-title":"The development of lacquer cracks in pathologic myopia","volume":"106","author":"Klein RM","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_9_12_1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0039-6257(82)90158-8","article-title":"Angioid streaks","volume":"26","author":"Clarkson JG","year":"1982","journal-title":"Surv Ophthalmol"},{"key":"e_1_2_9_13_1","first-page":"55","article-title":"Angioid streaks","volume":"11","author":"Donaldson EJ","year":"1983","journal-title":"Aust J Ophthalmol"},{"key":"e_1_2_9_14_1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004397-200004000-00009","article-title":"Ocular neovascularization in patients with uveitis","volume":"40","author":"Kuo IC","year":"2000","journal-title":"Int Ophthalmol Clin"},{"key":"e_1_2_9_15_1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s004170000186","article-title":"Hereditary retinal dystrophies and choroidal neovascularization","volume":"238","author":"Marano F","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"e_1_2_9_16_1","first-page":"34","article-title":"Using the Amsler grid","volume":"5","author":"Mattice E","year":"1986","journal-title":"J Ophthalmic Nurs Technol"},{"key":"e_1_2_9_17_1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bjo.86.6.663","article-title":"Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration","volume":"86","author":"Haddad WM","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"e_1_2_9_18_1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0021-5155(98)00008-2","article-title":"Indocyanine green angiographic findings of lacquer cracks in pathologic myopia","volume":"42","author":"Ohno\u2010Matsui K","year":"1998","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_2_9_19_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0161-6420(02)01563-4","article-title":"Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence\u2010based update","volume":"110","author":"Stanga PE","year":"2003","journal-title":"Ophthalmology"},{"key":"e_1_2_9_20_1","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age\u2010related macular degeneration","volume":"351","author":"Gragoudas ES","year":"2004","journal-title":"N Engl J Med"},{"key":"e_1_2_9_21_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00006982-200502000-00002","article-title":"Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age\u2010related macular degeneration and other causes: update","volume":"25","author":"Verteporfin Roundtable Participants","year":"2005","journal-title":"Retina"},{"key":"e_1_2_9_22_1","first-page":"269","article-title":"[Subretinal neovessels in degenerative myopia: results of photocoagulation.]","volume":"86","author":"Soubrane G","year":"1986","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"e_1_2_9_23_1","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/archopht.1987.01060110045029","article-title":"Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial","volume":"105","author":"Macular Photocoagulation Study Group","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_9_24_1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archopht.1989.01070010354023","article-title":"Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis","volume":"107","author":"Macular Photocoagulation Study Group","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_9_25_1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/archopht.1990.01070080074038","article-title":"Krypton laser photocoagulation for idiopathic neovascular lesions. Results of a randomized clinical trial","volume":"108","author":"Macular Photocoagulation Study Group","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_9_26_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00006982-199701000-00003","article-title":"Laser photocoagulation of choroidal neovascularization in angioid streaks","volume":"17","author":"Pece A","year":"1997","journal-title":"Retina"},{"key":"e_1_2_9_27_1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0161-6420(84)34116-1","article-title":"Natural history of choroidal neovascularization in degenerative myopia","volume":"91","author":"Avila MP","year":"1984","journal-title":"Ophthalmology"},{"key":"e_1_2_9_28_1","first-page":"721","article-title":"Choroidal neovascularization in degenerative myopia: role of laser photocoagulation","volume":"18","author":"Jalkh AE","year":"1987","journal-title":"Ophthalmic Surg"},{"key":"e_1_2_9_29_1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0161-6420(02)01998-X","article-title":"Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia:2\u2010year results of a randomized clinical trial\u2014VIP report no. 3","volume":"110","author":"Verteporfin In Photodynamic Therapy (VIP) Study Group","year":"2003","journal-title":"Ophthalmology"},{"key":"e_1_2_9_30_1","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.ophtha.2004.08.002","article-title":"Verteporfin in Photodynamic Therapy: report no. 5","volume":"111","author":"Bandello F","year":"2004","journal-title":"Ophthalmology"},{"key":"e_1_2_9_31_1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ophtha.2004.02.014","article-title":"Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open\u2010label 2\u2010year study","volume":"111","author":"Rosenfeld PJ","year":"2004","journal-title":"Ophthalmology"},{"key":"e_1_2_9_32_1","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0161-6420(02)01103-X","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one\u2010year results of an uncontrolled, prospective case series","volume":"109","author":"Saperstein DA","year":"2002","journal-title":"Ophthalmology"},{"key":"e_1_2_9_33_1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00006982-200306000-00003","article-title":"Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome","volume":"23","author":"Busquets MA","year":"2003","journal-title":"Retina"},{"key":"e_1_2_9_34_1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3928\/1542-8877-20030701-11","article-title":"Photodynamic therapy with verteporfin for subretinal neovascularization secondary to bilateral idiopathic acquired juxtafoveolar telangiectasis","volume":"34","author":"Hershberger VS","year":"2003","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"e_1_2_9_35_1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0002-9394(02)01626-4","article-title":"Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks","volume":"134","author":"Karacorlu M","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_9_36_1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00006982-200410000-00013","article-title":"Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy","volume":"24","author":"Menchini U","year":"2004","journal-title":"Retina"},{"key":"e_1_2_9_37_1","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0002-9394(02)02224-9","article-title":"Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in children","volume":"135","author":"Mimouni KF","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_9_38_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0002-9394(01)01205-3","article-title":"Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis","volume":"133","author":"Potter MJ","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_9_39_1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0161-6420(03)00466-4","article-title":"Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults","volume":"110","author":"Rogers AH","year":"2003","journal-title":"Ophthalmology"},{"key":"e_1_2_9_40_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(02)01835-4","article-title":"Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks","volume":"135","author":"Shaikh S","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_9_41_1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archopht.118.3.327","article-title":"A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes","volume":"118","author":"Sickenberg M","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_9_42_1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0002-9394(02)01452-6","article-title":"Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin","volume":"134","author":"Spaide RF","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_9_43_1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00006982-200210000-00002","article-title":"Effects of verteporfin therapy on contrast on sensitivity: results from the Treatment of Age\u2010Related Macular Degeneration With Photodynamic Therapy (TAP) investigation\u2014TAP report No 4","volume":"22","author":"Rubin GS","year":"2002","journal-title":"Retina"},{"key":"e_1_2_9_44_1","article-title":"SLO macular scotoma size benefitted by PDT","volume":"43","author":"Fletcher DC","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_9_45_1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ajo.2003.11.059","article-title":"Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials\u2014TAP and VIP report no. 3","volume":"137","author":"Bressler SB","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_9_46_1","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archopht.122.11.1597","article-title":"Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9","volume":"122","author":"Davidorf FH","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"e_1_2_9_47_1","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/BF02343047","article-title":"Surgical removal of idiopathic, myopic and age\u2010related subfoveal neovascularization","volume":"234","author":"Bottoni F","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"e_1_2_9_48_1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/bjo.84.8.919","article-title":"Helping blind and partially sighted people to read: the effectiveness of low vision aids","volume":"84","author":"Margrain TH","year":"2000","journal-title":"Br J Ophthalmol"}],"container-title":["Optometry and Vision Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/01.opx.0000216019.88256.eb","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1097\/01.opx.0000216019.88256.eb","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/01.opx.0000216019.88256.eb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:02:40Z","timestamp":1774944160000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/01.opx.0000216019.88256.eb"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["10.1097\/01.opx.0000216019.88256.eb"],"URL":"https:\/\/doi.org\/10.1097\/01.opx.0000216019.88256.eb","archive":["Portico"],"relation":{},"ISSN":["1040-5488","1538-9235"],"issn-type":[{"value":"1040-5488","type":"print"},{"value":"1538-9235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}